SCHEMBL845003

SCHEMBL845003

O=C(Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)C3Cc4ccccc43)cc2)cc1)[C@@H]1CCCN1C(=O)C1Cc2ccccc21

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
F2 P00734 2/20 0.58
ALDH1A1 P00352 3/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
PABPC1 P11940 1/20 0.45
MAPK1 P28482 2/20 0.44
HTT P42858 1/20 0.44
NPC1 O15118 1/20 0.43
LMNA P02545 2/20 0.43
GAA P10253 1/20 0.43
KDM4E B2RXH2 1/20 0.43
HSD17B10 Q99714 1/20 0.42
EP300 Q09472 1/20 0.42
CREBBP Q92793 1/20 0.42
KDM1A O60341 1/20 0.41
RCOR1 Q9UKL0 1/20 0.41
KCNH2 Q12809 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL845507 0.91 F2 (0.50) F2ALDH1A1CYP2C9CYP2C19PABPC1
SCHEMBL844884 0.81 HTT (0.48) ALDH1A1CYP2C9CYP2C19PABPC1MAPK1
SCHEMBL845255 0.79 CYP2C9 (0.47) ALDH1A1CYP2C9CYP2C19PABPC1MAPK1
SCHEMBL845346 0.78 ALDH1A1 (0.53) ALDH1A1CYP2C9CYP2C19PABPC1MAPK1
SCHEMBL13272391 0.78 ALDH1A1 (0.53) ALDH1A1CYP2C9CYP2C19PABPC1MAPK1
SCHEMBL845300 0.78 CYP2C9 (0.54) ALDH1A1CYP2C9CYP2C19PABPC1MAPK1
SCHEMBL845030 0.78 ALDH1A1 (0.49) ALDH1A1CYP2C9CYP2C19PABPC1MAPK1
SCHEMBL845064 0.77 MAPK1 (0.48) ALDH1A1CYP2C9CYP2C19PABPC1MAPK1
SCHEMBL15116912 0.77 ALDH1A1 (0.56) ALDH1A1CYP2C9CYP2C19PABPC1MAPK1
SCHEMBL845205 0.77 ALDH1A1 (0.56) ALDH1A1CYP2C9CYP2C19PABPC1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed